A Tubulin inhibitor, N-(5-benzyl-1,3-thiazol-2-yl)-3-(furan-2-yl)prop-2-enamide, induces anti-inflammatory innate immune responses to attenuate LPS-mediated septic shock

Hyun Jung Park, Sung Won Lee, Hwangseo Park, Se-Ho Park, Seokmann Hong

Research output: Contribution to journalArticle

Abstract

The anti-inflammatory effect of a tubulin inhibitor, N-(5-benzyl-1,3-thiazol-2-yl)-3-(furan-2-yl)prop-2-enamide (1), on innate immune responses remains unclear. Thus, we investigated the effect of 1 on the immune responses mediated by lipopolysaccharide (LPS). The in vitro addition of 1 to dendritic cells and macrophages dose-dependently reduced tumor necrosis factor alpha production elicited by LPS stimulation. Additionally, the stimulation of natural killer (NK) and natural killer T (NKT) cells with 1 resulted in the decrease of interferon gamma (IFNγ) induced by LPS treatment. Moreover, 1 substantially reduced interleukin 12 in dendritic cells (DC) as well as IFNγ in NKDCs induced by LPS in vitro. Furthermore, the in vivo administration of 1 ameliorated LPS/D-galactosamine-induced endotoxic lethality in mice. Taken together, our results demonstrate for the first time that 1 possesses anti-inflammatory properties, most notably by modulating LPS-induced innate immune responses. Therefore, 1 might have therapeutic potential for the treatment of inflammation-mediated diseases such as sepsis.

Original languageEnglish
Pages (from-to)3307-3312
Number of pages6
JournalBulletin of the Korean Chemical Society
Volume35
Issue number11
DOIs
Publication statusPublished - 2014 Nov 20

Fingerprint

Tubulin Modulators
Lipopolysaccharides
Anti-Inflammatory Agents
Interferon-gamma
Galactosamine
T-cells
Macrophages
Interleukin-12
furan
Tumor Necrosis Factor-alpha

Keywords

  • Anti-inflammatory
  • Anticancer
  • N-(5-benzyl-1,3-thiazol-2-yl)-3-(furan-2-yl)prop-2-enamide
  • Sepsis
  • Tubulin inhibitor

ASJC Scopus subject areas

  • Chemistry(all)

Cite this

A Tubulin inhibitor, N-(5-benzyl-1,3-thiazol-2-yl)-3-(furan-2-yl)prop-2-enamide, induces anti-inflammatory innate immune responses to attenuate LPS-mediated septic shock. / Park, Hyun Jung; Lee, Sung Won; Park, Hwangseo; Park, Se-Ho; Hong, Seokmann.

In: Bulletin of the Korean Chemical Society, Vol. 35, No. 11, 20.11.2014, p. 3307-3312.

Research output: Contribution to journalArticle

@article{7287e4b996e34e118abd2ec8cb2ae788,
title = "A Tubulin inhibitor, N-(5-benzyl-1,3-thiazol-2-yl)-3-(furan-2-yl)prop-2-enamide, induces anti-inflammatory innate immune responses to attenuate LPS-mediated septic shock",
abstract = "The anti-inflammatory effect of a tubulin inhibitor, N-(5-benzyl-1,3-thiazol-2-yl)-3-(furan-2-yl)prop-2-enamide (1), on innate immune responses remains unclear. Thus, we investigated the effect of 1 on the immune responses mediated by lipopolysaccharide (LPS). The in vitro addition of 1 to dendritic cells and macrophages dose-dependently reduced tumor necrosis factor alpha production elicited by LPS stimulation. Additionally, the stimulation of natural killer (NK) and natural killer T (NKT) cells with 1 resulted in the decrease of interferon gamma (IFNγ) induced by LPS treatment. Moreover, 1 substantially reduced interleukin 12 in dendritic cells (DC) as well as IFNγ in NKDCs induced by LPS in vitro. Furthermore, the in vivo administration of 1 ameliorated LPS/D-galactosamine-induced endotoxic lethality in mice. Taken together, our results demonstrate for the first time that 1 possesses anti-inflammatory properties, most notably by modulating LPS-induced innate immune responses. Therefore, 1 might have therapeutic potential for the treatment of inflammation-mediated diseases such as sepsis.",
keywords = "Anti-inflammatory, Anticancer, N-(5-benzyl-1,3-thiazol-2-yl)-3-(furan-2-yl)prop-2-enamide, Sepsis, Tubulin inhibitor",
author = "Park, {Hyun Jung} and Lee, {Sung Won} and Hwangseo Park and Se-Ho Park and Seokmann Hong",
year = "2014",
month = "11",
day = "20",
doi = "10.5012/bkcs.2014.35.11.3307",
language = "English",
volume = "35",
pages = "3307--3312",
journal = "Bulletin of the Korean Chemical Society",
issn = "0253-2964",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - A Tubulin inhibitor, N-(5-benzyl-1,3-thiazol-2-yl)-3-(furan-2-yl)prop-2-enamide, induces anti-inflammatory innate immune responses to attenuate LPS-mediated septic shock

AU - Park, Hyun Jung

AU - Lee, Sung Won

AU - Park, Hwangseo

AU - Park, Se-Ho

AU - Hong, Seokmann

PY - 2014/11/20

Y1 - 2014/11/20

N2 - The anti-inflammatory effect of a tubulin inhibitor, N-(5-benzyl-1,3-thiazol-2-yl)-3-(furan-2-yl)prop-2-enamide (1), on innate immune responses remains unclear. Thus, we investigated the effect of 1 on the immune responses mediated by lipopolysaccharide (LPS). The in vitro addition of 1 to dendritic cells and macrophages dose-dependently reduced tumor necrosis factor alpha production elicited by LPS stimulation. Additionally, the stimulation of natural killer (NK) and natural killer T (NKT) cells with 1 resulted in the decrease of interferon gamma (IFNγ) induced by LPS treatment. Moreover, 1 substantially reduced interleukin 12 in dendritic cells (DC) as well as IFNγ in NKDCs induced by LPS in vitro. Furthermore, the in vivo administration of 1 ameliorated LPS/D-galactosamine-induced endotoxic lethality in mice. Taken together, our results demonstrate for the first time that 1 possesses anti-inflammatory properties, most notably by modulating LPS-induced innate immune responses. Therefore, 1 might have therapeutic potential for the treatment of inflammation-mediated diseases such as sepsis.

AB - The anti-inflammatory effect of a tubulin inhibitor, N-(5-benzyl-1,3-thiazol-2-yl)-3-(furan-2-yl)prop-2-enamide (1), on innate immune responses remains unclear. Thus, we investigated the effect of 1 on the immune responses mediated by lipopolysaccharide (LPS). The in vitro addition of 1 to dendritic cells and macrophages dose-dependently reduced tumor necrosis factor alpha production elicited by LPS stimulation. Additionally, the stimulation of natural killer (NK) and natural killer T (NKT) cells with 1 resulted in the decrease of interferon gamma (IFNγ) induced by LPS treatment. Moreover, 1 substantially reduced interleukin 12 in dendritic cells (DC) as well as IFNγ in NKDCs induced by LPS in vitro. Furthermore, the in vivo administration of 1 ameliorated LPS/D-galactosamine-induced endotoxic lethality in mice. Taken together, our results demonstrate for the first time that 1 possesses anti-inflammatory properties, most notably by modulating LPS-induced innate immune responses. Therefore, 1 might have therapeutic potential for the treatment of inflammation-mediated diseases such as sepsis.

KW - Anti-inflammatory

KW - Anticancer

KW - N-(5-benzyl-1,3-thiazol-2-yl)-3-(furan-2-yl)prop-2-enamide

KW - Sepsis

KW - Tubulin inhibitor

UR - http://www.scopus.com/inward/record.url?scp=84926672954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926672954&partnerID=8YFLogxK

U2 - 10.5012/bkcs.2014.35.11.3307

DO - 10.5012/bkcs.2014.35.11.3307

M3 - Article

VL - 35

SP - 3307

EP - 3312

JO - Bulletin of the Korean Chemical Society

JF - Bulletin of the Korean Chemical Society

SN - 0253-2964

IS - 11

ER -